Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants
Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants
Recruiting · NCT05670951 · Registry updated 2026-01-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants | Digestive System Diseases, Nutritional and Metabolic Diseases, digestive system disorder, intestinal disorder, malabsorption syndrome, metabolic disease | Recruiting | Phase 3 | 2026-01-23 | NCT05670951 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Elgan Pharma Ltd. | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Laniado Hospital | Netanya | Israel | 1 |